跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dilatair - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dilatair
Approved
STANDARD
Dilatair
Ajanta Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f802011662a58c9d
Company
Ajanta Pharma Limited
Type
Standard
Approval Details
Approval Id
f802011662a58c9d
Drug Approval Philippines Name
Dilatair
Product Name
Dilatair
Registration Number
DR-XY48055
Brand Name
Dilatair
Generic Name
Doxofylline
Dosage Form
Tablet
Dosage Strength
200 mg
Manufacturer
Ajanta Pharma Limited
Importer
The Cathay Drug Co., Inc.
Distributor
The Cathay Drug Co., Inc.
Company Detail Path
/organization/ajanta-pharma-limited
Issuance Date
26 May 2022
Expiry Date
26 May 2027
Pharmacologic Category
Bronchodilator
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f802011662a58c9d
Type
Standard
Back to Philippines FDA Approvals